BullFrog AI Announces Positive Progress in Drug Discovery Program for Top 5 Global Pharmaceutical in Major Depressive Disorder
BullFrog AI says it has achieved key project milestones with a top 5 global pharmaceutical company, reporting that its AI platform identified and prioritized novel therapeutic targets for major depressive disorder. The company also highlights broader programs applying its platform to schizophrenia, bipolar disorder, and other therapeutic areas.